Comparison of inpatient glycemic control with insulin vials versus insulin pens in general medicine patients

Hospital Pharmacy

Volumn 50, Issue 6, 2015, Pages 514-521

  Horne, Juliann ^a   Bond, Rucha ^a   Sarangarm, Preeyaporn ^b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Blood glucose; Diabetes mellitus; Drug delivery systems; Injections; Inpatient; Insulin; Subcutaneous; Type 2

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE; INSULIN LISPRO; SHORT ACTING INSULIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; COHORT ANALYSIS; DIABETIC KETOACIDOSIS; DRUG DELIVERY DEVICE; FEMALE; GENERAL PRACTICE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN INJECTION PEN; INSULIN TREATMENT; INSULIN VIAL; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PARENTERAL NUTRITION; RETROSPECTIVE STUDY;

EID: 84975686283     PISSN: 00185787     EISSN: 19451253     Source Type: Journal    
DOI: 10.1310/hpj5006-514     Document Type: Article

References (33)

1. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978-982.
2. Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61(4):284-289.
3. Bruno A, Gregori D, Caropreso A, Lazzarato F, Petrinco M, Pagano E. Normal glucose values are associated with a lower risk of mortality in hospitalized patients. Diabetes Care. 2008;31(11):2209-2210.
4. Noordzij PG, Boersma E, Schreiner F, et al. Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol. 2007;156(1):137-142.
5. Pomposelli JJ, Baxter JK, 3rd, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. J Parenter Enteral Nutr. 1998;22(2):77-81.
6. McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ. The relation between hyperglycemia and outcomes in 2, 471 patients admitted to the hospital with communityacquired pneumonia. Diabetes Care. 2005;28(4):810-815.
7. Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009;32(7):1153-1157.
8. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care. 2010;33(6):1389-1394.
9. Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16-38.
10. Standards of medical care in diabetes-2014. Diabetes Care. 2014;37(suppl 1):S14-80.
11. Le Floch J P, Herbreteau C, Lange F, Perlemuter L. Biologic material in needles and cartridges after insulin injection with a pen in diabetic patients. Diabetes Care. 1998;21(9):1502-1504.
12. Sonoki K, Yoshinari M, Iwase M, et al. Regurgitation of blood into insulin cartridges in the pen-like injectors. Diabetes Care. 2001;24(3):603-604.
13. Herdman ML, Larck C, Schliesser SH, Jelic TM. Biological contamination of insulin pens in a hospital setting. Am J Health Syst Pharm. 2013;70(14):1244-1248.
14. Institute for Safe Medication Practices. Ongoing concern about insulin pen reuse shows hospitals need to consider transitioning away from them. ISMP Medication Safety Alert! [serial online]. 2013;18(3):1-2.
15. Allison DB, Paultre F, Maggio C, Mezzitis N, Pi-Sunyer FX. The use of areas under curves in diabetes research. Diabetes Care. 1995;18(2):245-250.
16. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J. 1990;300(6719):230-235.
17. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med. 1997;157(5):545-552.
18. Maruyama S, Sakura H, Kanno H, Iwamoto Y. Factors associated with glycemic control after an inpatient program. Metabolism. 2009;58(6):843-847.
19. The Centers for Disease Control and Prevention. CDC clinical reminder: Insulin pens must never be used for more than one person. http://www.cdc.gov/injectionsafety/clinicalreminders/insulin-pens.html. Accessed August 1, 2013.
20. Information for healthcare professionals: Risk of transmission of bloodborne pathogens from shared use of insulin pens. US Food and Drug Administration Postmarket Drug Safety Information for Patients and Providers. http://www.fda. gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationfor-PatientsandProviders/DrugSafetyInformationforHeathcare-Professionals/ucm133352.htm. Accessed August 18, 2013.
21. Centers for Medicare & Medicaid Services. Memorandum: Use of insulin pens in health care facilities. May 18, 2012. Office of Clinical Standards and Quality/Survey & Certification Group. http://www.cms.gov/Medicare/Provider-Enrollment-andcertification/SurveyCertificationGenInfo/Downloads/Surveyand-Cert-Letter-12-30.pdf. Accessed April 7, 2014.
22. Ochs R. South Nassau Hospital alerting 4, 247 patients of possible blood contamination. Newsday. March 11, 2014. http://www.newsday.com/news/health/south-nassau-hospitalalerting-4-247-patients-of-possible-blood-contamination-1.7359969. Accessed April 7, 2014.
23. McCarthy D. Olean General alerts patients to possible insulin pen re-use. Press release, Olean General Hospital. January 24, 2013. http://www.ogh.org/programs-and-services/diabetes/Press%20Release-OGH%20Alerts%20Patients%20 to%20Possible%20Insulin%20Pen%20Re-use.pdf. Accessed April 7, 2014.
24. Whitman V. Catskill Hospital warns that insulin pens may have been reused. Times Herald-Record. May 21, 2013. http://www.recordonline.com/apps/pbcs.dll/article?AID=/20130521/NEWS/130529929. Accessed April 7, 2014.
25. Cook E. Misuse of insulin pens at VA leads to testing. Salisbury Post. March 8, 2013. http://www.salisburypost.com/article/20130308/SP01/130309740/. Accessed April 7, 2014.
26. N. Y. hospital patients potentially exposed to HIV, hepatitis through reused insulin pens. CBS News. January 24, 2013. http://www.cbsnews.com/news/ny-hospital-patientspotentially-exposed-to-hiv-hepatitis-through-reused-insulinpens/. Accessed April 7, 2014.
27. Cobaugh DJ, Maynard G, Cooper L, et al. Enhancing insulin-use safety in hospitals: Practical recommendations from an ASHP Foundation expert consensus panel. Am J Health Syst Pharm. 2013;70(16):1404-1413.
28. Luijf YM, DeVries JH. Dosing accuracy of insulin pens versus conventional syringes and vials. Diabetes Technol Ther. 2010;12(suppl 1):S73-77.
29. Instructions for use HUMALOG KwikPen insulin lispro injection (rDNA origin). http://pi.lilly.com/us/humalogkwikpen-um.pdf. Accessed August 14, 2013.
30. Novolog (insulin aspart [rDNA origin] injection) [package insert]. Bagsvaerd, Denmark: Novo Nordisk A/S; October 2013.
31. How to use your Lantus Solostar pen. 2013. Sanof-Aventis U. S. LLC. http://www.lantus.com/docs/pdf/SoloSTAR-QRG.pdf. Accessed April 18, 2014.
32. Institute for Safe Medication Practices. Considering insulin pens for routine hospital use? Consider this⋯ ISMP Medication Safety Alert! Acute Care Newsletter [serial online]. May 8, 2008; Doc no. 1.
33. Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucometrics in patients hospitalized with acute myocardial infarction: Defning the optimal outcomes-based measure of risk. Circulation. 2008;117(8):1018-1027.